Nurea
PrivateLast Round
Seed
Sep 9, 2024
Total Funding Raised
$4.56M
Company Overview
Nurea is a health-tech company that develops AI-powered medical imaging software to aid in the diagnosis and monitoring of cardiovascular and neurovascular diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical AI, Medical Devices, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nurea Comparables
Compare Nurea with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PrediSurge | 84% | |
| RapidAI | 78% | |
| Viz.ai | 75% | |
Nurea Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 9, 2024 | ||||
| Seed | Jun 30, 2022 | ||||
| Grant | Jun 2, 2020 | ||||
| Grant | Jul 4, 2019 |
Key People
Founding team and executive leadership
Nurea Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bpifrance | Seed |
| Paris Business Angels | Seed |
| Techno'Start | Seed |
| EIT Health | Grant |
| Aquitaine Science Transfert | Seed |
| Bpifrance | Seed, Grant |
| Newfund Capital | Seed |
Nurea Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nurea's valuation, stock price, and market status.